305434324	305434324	CD	B-NP	O
|	|	NN	I-NP	O
RCMH	RCMH	NN	I-NP	O
|	|	NN	I-NP	O
24774612	24774612	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
329811	329811	CD	B-NP	O
|	|	CC	I-NP	O
3/8/1996	3/8/1996	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Unsigned	Unsigned	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/5/1996	1/5/1996	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Unsigned	Unsigned	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/3/1996	2/3/1996	CD	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
CORONARY	CORONARY	NN	B-NP	O
ARTERY	ARTERY	NN	I-NP	O
DISEASE	DISEASE	NN	I-NP	O
AND	AND	CC	O	O
MIXED	MIXED	NNP	B-NP	O
MITRAL	MITRAL	NNP	I-NP	O
VALVE	VALVE	NNP	I-NP	O
DISEASE	DISEASE	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
OF	OF	IN	B-PP	O
THE	THE	DT	B-NP	O
PRESENT	PRESENT	JJ	I-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
Ms.	Ms.	NNP	B-NP	O
Reda	Reda	NNP	I-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
87	87	CD	I-NP	O
year-old	year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
mitral	mitral	JJ	B-NP	O
regurgitation	regurgitation	NN	I-NP	O
and	and	CC	O	O
multiple	multiple	JJ	B-NP	O
sclerosis	sclerosis	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
complaining	complain	VBG	I-VP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
and	and	CC	I-NP	O
pressure	pressure	NN	I-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
dyspnea	dyspnea	NN	B-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
limitation	limitation	NN	B-NP	O
of	of	IN	B-PP	O
activity	activity	NN	B-NP	O
and	and	CC	O	O
increasing	increase	VBG	B-VP	O
sublingual	sublingual	JJ	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
use	use	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
six	six	CD	I-NP	O
to	to	TO	I-NP	O
seven	seven	CD	I-NP	O
months	month	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
developed	develop	VBD	B-VP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
atrial	atrial	JJ	B-NP	O
flutter	flutter	NN	I-NP	O
back	back	RB	B-ADVP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
,	,	,	O	O
1995	1995	CD	B-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
40	40	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
inferior	inferior	JJ	B-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
,	,	,	O	O
moderate	moderate	JJ	B-NP	O
mitral	mitral	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
atrial	atrial	JJ	I-NP	O
size	size	NN	I-NP	O
of	of	IN	B-PP	O
6.1	6.1	CD	B-NP	O
centimeters	centimeter	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
required	require	VBD	B-VP	O
hospitalization	hospitalization	NN	B-NP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
,	,	,	O	O
1996	1996	CD	B-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
returned	return	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
in	in	IN	B-PP	O
February	February	NNP	B-NP	O
,	,	,	O	O
1996	1996	CD	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
complaints	complaint	NNS	B-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
and	and	CC	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
ruled	rule	VBN	I-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
myocardial	myocardial	JJ	B-NP	O
infarction	infarction	NN	I-NP	O
at	at	IN	B-PP	O
Tol	Tol	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
and	and	CC	O	O
transferred	transfer	VBN	B-VP	O
to	to	TO	B-PP	O
Ana	Ana	NNP	B-NP	O
Vinerl	Vinerl	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
,	,	,	O	O
where	where	WRB	B-ADVP	O
she	she	PRP	B-NP	O
refused	refuse	VBD	B-VP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
.	.	.	O	O

Echocardiogram	Echocardiogram	NN	B-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
45	45	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
inferior	inferior	JJ	B-NP	O
,	,	,	I-NP	O
posterior	posterior	JJ	I-NP	O
and	and	CC	I-NP	O
anterior	anterior	JJ	I-NP	O
septal	septal	JJ	I-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-ADJP	O
to	to	TO	B-PP	O
moderate	moderate	JJ	B-NP	O
mitral	mitral	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
and	and	CC	O	O
moderate	moderate	JJ	B-NP	O
mitral	mitral	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
.	.	.	O	O

Again	Again	RB	B-ADVP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
left	left	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
enlargement	enlargement	NN	I-NP	O
measured	measure	VBN	B-VP	O
at	at	IN	B-PP	O
6.1	6.1	CD	B-NP	O
centimeters	centimeter	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
returned	return	VBD	B-VP	O
home	home	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
doing	do	VBG	I-VP	O
well	well	RB	B-ADVP	O
until	until	IN	B-PP	O
February	February	NNP	B-NP	O
,	,	,	O	O
1996	1996	CD	B-NP	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
developed	develop	VBD	B-VP	O
headache	headache	NN	B-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
and	and	CC	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
again	again	RB	B-ADVP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
Beth	Beth	NNP	B-NP	O
's	's	POS	B-NP	O
Community	Community	NNP	I-NP	O
Memorial	Memorial	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
where	where	WRB	B-ADVP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
in	in	IN	B-PP	O
acute	acute	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
stabilized	stabilize	VBN	I-VP	O
and	and	CC	O	O
transferred	transfer	VBN	B-VP	O
to	to	TO	B-PP	O
Crithouse	Crithouse	NNP	B-NP	O
County	County	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
management	management	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	VBD	B-VP	O
anterior	anterior	JJ	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
.	.	.	O	O

Mitral	Mitral	JJ	B-NP	O
regurgitation	regurgitation	NN	I-NP	O
.	.	.	O	O

Mitral	Mitral	JJ	B-NP	O
stenosis	stenosis	NN	I-NP	O
.	.	.	O	O

Atrial	Atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

Hypothyroidism	Hypothyroidism	NN	B-NP	O
.	.	.	O	O

Gastroesophageal	Gastroesophageal	JJ	B-NP	O
reflux	reflux	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Peptic	Peptic	JJ	B-NP	O
ulcer	ulcer	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Normocytic	Normocytic	JJ	B-NP	O
anemia	anemia	NN	I-NP	O
.	.	.	O	O

Polymyalgia	Polymyalgia	NN	B-NP	O
rheumatica	rheumatica	NN	I-NP	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
left	left	JJ	B-NP	O
humeral	humeral	JJ	I-NP	O
fracture	fracture	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
appendectomy	appendectomy	NN	I-NP	O
,	,	,	O	O
cholecystectomy	cholecystectomy	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
laser	laser	NN	B-NP	O
therapy	therapy	NN	I-NP	O
for	for	IN	B-PP	O
retinal	retinal	JJ	B-NP	O
disease	disease	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
eye	eye	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Erythromycin	Erythromycin	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
causes	cause	VBZ	B-VP	O
vomiting	vomiting	NN	B-NP	O
and	and	CC	I-NP	O
hypertension	hypertension	NN	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
to	to	TO	B-PP	O
sulfa	sulfa	NN	B-NP	O
drugs	drug	NNS	I-NP	O
which	which	WDT	B-NP	O
cause	cause	VBP	B-VP	O
vomiting	vomit	VBG	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
possible	possible	JJ	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
penicillin	penicillin	NN	B-NP	B-protein
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Synthroid	Synthroid	JJ	B-NP	O
100	100	CD	I-NP	O
micrograms	microgram	NNS	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
;	;	:	O	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
;	;	:	O	O
Axid	Axid	NN	B-NP	O
150	150	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
;	;	:	O	O
aspirin	aspirin	NN	B-NP	O
325	325	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
;	;	:	O	O
prednisone	prednisone	NN	B-NP	O
5	5	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
;	;	:	O	O
digoxin	digoxin	NN	B-NP	O
0.125	0.125	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
;	;	:	O	O
Vasotec	Vasotec	NNP	B-NP	O
5	5	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
;	;	:	O	O
Zocor	Zocor	NNP	B-NP	O
10	10	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
;	;	:	O	O
Lopressor	Lopressor	NN	B-NP	O
25	25	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.i.d.	q.i.d.	FW	I-ADVP	O
;	;	:	O	O
Isordil	Isordil	NN	B-NP	O
10	10	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
t.i.d.	t.i.d.	FW	I-ADVP	O
;	;	:	O	O
Coumadin	Coumadin	NN	B-NP	O
alternating	alternate	VBG	B-VP	O
1	1	CD	B-NP	O
and	and	CC	I-NP	O
2	2	CD	I-NP	O
milligrams	milligram	NNS	I-NP	O
q.d.	q.d.	VBN	B-VP	O
On	On	IN	B-PP	O
transfer	transfer	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
on	on	IN	B-PP	O
intravenous	intravenous	JJ	B-NP	O
heparin	heparin	NN	I-NP	O
and	and	CC	I-NP	O
Nitropaste	Nitropaste	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
widowed	widow	VBN	I-VP	O
and	and	CC	I-VP	O
retired	retire	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
smoking	smoking	NN	I-NP	O
or	or	CC	I-NP	O
alcohol	alcohol	NN	I-NP	O
history	history	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
in	in	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
83	83	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
is	be	VBZ	B-VP	O
100/60	100/60	CD	B-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
upper	upper	JJ	B-NP	O
and	and	CC	I-NP	O
lower	low	JJR	I-NP	O
dentures	denture	NNS	I-NP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
oropharyngeal	oropharyngeal	JJ	I-NP	O
lesions	lesion	NNS	I-NP	O
.	.	.	O	O

NECK	NECK	NN	B-NP	O
:	:	:	O	O
Supple	Supple	NN	B-NP	O
with	with	IN	B-PP	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
carotid	carotid	NN	I-NP	O
pulses	pulse	NNS	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
bruits	bruit	NNS	I-NP	O
.	.	.	O	O

LUNGS	LUNGS	NN	B-NP	O
:	:	:	O	O
Bibasilar	Bibasilar	JJ	B-NP	O
crackles	crackle	NNS	I-NP	O
.	.	.	O	O

CARDIOVASCULAR	CARDIOVASCULAR	NN	B-NP	O
:	:	:	O	O
Irregularly	Irregularly	RB	B-NP	O
irregular	irregular	JJ	I-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

Normal	Normal	JJ	B-NP	O
S1/S2	S1/S2	NN	I-NP	O
.	.	.	O	O

III/VI	III/VI	CD	B-NP	O
holosystolic	holosystolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
radiating	radiate	VBG	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
apex	apex	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
axilla	axilla	NN	I-NP	O
.	.	.	O	O

ABDOMEN	ABDOMEN	NN	B-NP	O
:	:	:	O	O
Soft	Soft	NNP	B-NP	O
,	,	,	O	O
nontender	nontender	JJ	B-NP	O
,	,	,	I-NP	O
obese	obese	JJ	I-NP	O
.	.	.	O	O

EXTREMITIES	EXTREMITIES	NNS	B-NP	O
:	:	:	O	O
Without	Without	IN	B-PP	O
cyanosis	cyanosis	NN	B-NP	O
,	,	,	I-NP	O
clubbing	clubbing	NN	I-NP	O
or	or	CC	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
are	be	VBP	B-VP	O
varicosities	varicosity	NNS	B-NP	O
in	in	IN	B-PP	O
bilateral	bilateral	JJ	B-NP	O
lower	low	JJR	I-NP	O
extremities	extremity	NNS	I-NP	O
with	with	IN	B-PP	O
minimal	minimal	JJ	B-NP	O
varicosities	varicosity	NNS	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
thigh	thigh	JJ	I-NP	O
areas	area	NNS	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
bilateral	bilateral	JJ	B-NP	O
knee	knee	NN	I-NP	O
swelling	swelling	NN	I-NP	O
.	.	.	O	O

Pedal	Pedal	JJ	B-NP	O
pulses	pulse	NNS	I-NP	O
are	be	VBP	B-VP	O
1	1	CD	B-NP	O
+	+	SYM	B-VP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

NEUROLOGICAL	NEUROLOGICAL	NN	B-NP	O
:	:	:	O	O
Nonfocal	Nonfocal	JJ	B-ADJP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
BUN	BUN	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
35	35	CD	B-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
1.5	1.5	CD	I-NP	O
.	.	.	O	O

White	White	JJ	B-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
8.3	8.3	CD	I-NP	O
.	.	.	O	O

Hematocrit	Hematocrit	NN	B-NP	B-protein
32	32	CD	I-NP	I-protein
.	.	.	O	O

PT	PT	NN	B-NP	B-protein
11.9	11.9	CD	I-NP	I-protein
,	,	,	O	O
PTT	PTT	NN	B-NP	B-protein
28.4	28.4	CD	I-NP	I-protein
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Jeffganlanda	Jeffganlanda	NNP	I-NP	O
Py	Py	NNP	I-NP	O
Docweli	Docweli	NNP	I-NP	O
Skiffle	Skiffle	NNP	I-NP	O
Community	Community	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
Cardiology	Cardiology	NNP	I-NP	O
Service	Service	NNP	I-NP	O
,	,	,	O	O
where	where	WRB	B-ADVP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
maximized	maximize	VBN	I-VP	O
medically	medically	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
on	on	IN	B-PP	O
January	January	NNP	B-NP	O
,	,	,	O	O
1996	1996	CD	B-NP	O
,	,	,	O	O
where	where	WRB	B-ADVP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
right	right	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mid	mid	JJ	I-NP	O
portion	portion	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
distally	distally	RB	B-VP	O
had	have	VBD	I-VP	O
80	80	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Finally	Finally	RB	B-ADVP	O
,	,	,	O	O
90	90	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
subtotal	subtotal	JJ	B-NP	O
occlusion	occlusion	NN	I-NP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
posterior	posterior	JJ	I-NP	O
descending	descend	VBG	I-NP	O
artery	artery	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
left	left	JJ	I-NP	O
anterior	anterior	JJ	I-NP	O
descending	descend	VBG	I-NP	O
artery	artery	NN	I-NP	O
had	have	VBD	B-VP	O
40	40	CD	B-NP	O
%	%	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
after	after	IN	B-PP	O
diagonal	diagonal	JJ	B-NP	O
1	1	CD	I-NP	O
.	.	.	O	O

Diagonal	Diagonal	JJ	B-NP	O
1	1	CD	I-NP	O
itself	itself	PRP	B-NP	O
had	have	VBD	B-VP	O
90	90	CD	B-NP	O
%	%	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mid	mid	JJ	I-NP	O
portion	portion	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
left	left	JJ	I-NP	O
circumflex	circumflex	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
70	70	CD	I-NP	O
%	%	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
mid	mid	JJ	I-NP	O
portion	portion	NN	I-NP	O
and	and	CC	O	O
another	another	DT	B-NP	O
70	70	CD	I-NP	O
%	%	NN	I-NP	O
stenotic	stenotic	JJ	I-NP	O
area	area	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
distal	distal	JJ	I-NP	B-DNA
portion	portion	NN	I-NP	I-DNA
.	.	.	O	O

Left	Leave	VBN	B-NP	O
ventricular	ventricular	JJ	I-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
was	be	VBD	B-VP	O
estimated	estimate	VBN	I-VP	O
at	at	IN	B-PP	O
45	45	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Inferior	Inferior	JJ	B-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
as	as	IN	B-SBAR	O
was	be	VBD	B-VP	O
3-4	3-4	CD	B-NP	O
+	+	SYM	I-NP	O
mitral	mitral	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
.	.	.	O	O

Right	Right	RB	B-NP	O
atrial	atrial	JJ	I-NP	O
pressures	pressure	NNS	I-NP	O
were	be	VBD	B-VP	O
6	6	CD	B-NP	O
,	,	,	O	O
right	right	JJ	B-NP	O
ventricle	ventricle	NN	I-NP	O
was	be	VBD	B-VP	O
52/10	52/10	CD	B-NP	O
,	,	,	O	O
pulmonary	pulmonary	JJ	B-NP	O
artery	artery	NN	I-NP	O
52/22	52/22	CD	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
mean	mean	NN	B-NP	O
of	of	IN	B-PP	O
33	33	CD	B-NP	O
,	,	,	O	O
pulmonary	pulmonary	JJ	B-NP	O
capillary	capillary	JJ	I-NP	O
wedge	wedge	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
27	27	CD	B-NP	O
and	and	CC	O	O
left	left	JJ	B-NP	O
ventricle	ventricle	NN	I-NP	O
was	be	VBD	B-VP	O
160/16	160/16	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Cardiac	Cardiac	NNP	I-NP	O
Surgical	Surgical	NNP	I-NP	O
Service	Service	NNP	I-NP	O
for	for	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
bypass	bypass	IN	B-PP	O
grafting	grafting	NN	B-NP	O
and	and	CC	I-NP	O
replacement	replacement	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
mitral	mitral	JJ	I-NP	O
valve	valve	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
March	March	NNP	B-NP	O
,	,	,	O	O
1996	1996	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Operating	Operating	NNP	I-NP	O
Room	Room	NNP	I-NP	O
where	where	WRB	B-ADVP	O
she	she	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
bypass	bypass	IN	B-PP	O
grafting	graft	VBG	B-VP	O
times	time	NNS	B-NP	O
four	four	CD	B-NP	O
with	with	IN	B-PP	O
saphenous	saphenous	JJ	B-NP	O
vein	vein	NN	I-NP	O
graft	graft	NN	I-NP	O
to	to	TO	B-PP	O
posterior	posterior	JJ	B-NP	O
descending	descend	VBG	I-NP	O
artery	artery	NN	I-NP	O
,	,	,	O	O
saphenous	saphenous	JJ	B-NP	O
vein	vein	NN	I-NP	O
graft	graft	NN	I-NP	O
to	to	TO	B-VP	O
obtuse	obtuse	VB	I-VP	O
marginal	marginal	JJ	B-NP	O
one	one	CD	I-NP	O
,	,	,	O	O
saphenous	saphenous	JJ	B-NP	O
vein	vein	NN	I-NP	O
graft	graft	NN	I-NP	O
to	to	TO	B-VP	O
left	left	VB	I-VP	O
anterior	anterior	JJ	B-NP	O
descending	descend	VBG	I-NP	O
artery	artery	NN	I-NP	O
,	,	,	O	O
diagonal	diagonal	JJ	B-NP	O
one	one	CD	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
left	left	VB	I-VP	O
anterior	anterior	RB	B-NP	O
descending	descend	VBG	I-NP	O
artery	artery	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
mitral	mitral	JJ	B-NP	O
valve	valve	NN	I-NP	O
replacement	replacement	NN	I-NP	O
with	with	IN	B-PP	O
31	31	CD	B-NP	O
millimeter	millimeter	NN	I-NP	O
Hancock	Hancock	NNP	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
tolerated	tolerate	VBD	B-VP	O
the	the	DT	B-NP	O
procedure	procedure	NN	I-NP	O
well	well	RB	B-ADVP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
postoperatively	postoperatively	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Cardiac	Cardiac	NNP	I-NP	O
Intensive	Intensive	NNP	I-NP	O
Care	Care	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
on	on	IN	B-PP	O
nitroglycerin	nitroglycerin	NN	B-NP	O
,	,	,	O	O
Dopamine	Dopamine	NN	B-NP	O
drip	drip	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
weaned	wean	VBN	I-VP	O
to	to	TO	I-VP	O
extubate	extubate	VB	I-VP	O
without	without	IN	B-PP	O
difficulty	difficulty	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
Captopril	Captopril	NNP	B-NP	O
and	and	CC	O	O
digoxin	digoxin	NN	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
Coumadin	Coumadin	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
minimal	minimal	JJ	B-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
diuretics	diuretic	NNS	B-NP	O
,	,	,	O	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
rise	rise	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
to	to	TO	B-PP	O
1.9	1.9	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Captopril	Captopril	NNP	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
returned	return	VBD	B-VP	O
again	again	RB	B-ADVP	O
to	to	TO	B-PP	O
1.3	1.3	CD	B-NP	O
.	.	.	O	O

Although	Although	IN	B-SBAR	O
the	the	DT	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
small	small	JJ	B-NP	O
bilateral	bilateral	JJ	I-NP	O
pleural	pleural	JJ	I-NP	O
effusions	effusion	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
require	require	VB	I-VP	O
aggressive	aggressive	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
initially	initially	RB	B-ADVP	O
as	as	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
excellent	excellent	JJ	B-NP	O
oxygenation	oxygenation	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
Lopressor	Lopressor	NN	B-NP	O
as	as	IN	B-PP	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
remained	remain	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
90-100	90-100	CD	I-NP	O
range	range	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
started	start	VBN	B-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
prednisone	prednisone	NN	I-NP	O
at	at	IN	B-PP	O
5	5	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
Synthroid	Synthroid	NN	I-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
tubes	tube	NNS	I-NP	O
and	and	CC	O	O
invasive	invasive	JJ	B-NP	O
monitoring	monitoring	NN	I-NP	O
were	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
early	early	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
on	on	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
number	number	NN	I-NP	O
four	four	CD	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
physical	physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
and	and	CC	O	O
occupational	occupational	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
for	for	IN	B-PP	O
progression	progression	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
mobility	mobility	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
to	to	TO	I-VP	O
benefit	benefit	VB	I-VP	O
from	from	IN	B-PP	O
intensive	intensive	JJ	B-NP	O
rehabilitation	rehabilitation	NN	I-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
facility	facility	NN	I-NP	O
.	.	.	O	O

CONDITION	CONDITION	NN	B-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
ambulating	ambulate	VBG	I-VP	O
with	with	IN	B-PP	O
assistance	assistance	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
tolerating	tolerate	VBG	I-VP	O
a	a	DT	B-NP	O
regular	regular	JJ	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
in	in	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
but	but	CC	O	O
ventricular	ventricular	JJ	B-NP	O
response	response	NN	I-NP	O
was	be	VBD	B-VP	O
well	well	RB	I-VP	O
controlled	control	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
60s	60	NNS	I-NP	B-DNA
to	to	TO	B-PP	I-DNA
70s	70	NNS	B-NP	I-DNA
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
electrocardiogram	electrocardiogram	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
persistent	persistent	JJ	B-NP	O
right	right	JJ	I-NP	O
bundle	bundle	NN	I-NP	O
branch	branch	NN	I-NP	O
block	block	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
anterior	anterior	JJ	I-NP	O
fascicular	fascicular	JJ	I-NP	O
block	block	NN	I-NP	O
.	.	.	O	O

Although	Although	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
receiving	receive	VBG	I-VP	O
more	more	RBR	B-ADVP	O
than	than	IN	B-PP	O
her	her	PRP$	B-NP	O
normal	normal	JJ	I-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
had	have	VBD	B-VP	O
not	not	RB	I-VP	O
reached	reach	VBN	I-VP	O
the	the	DT	B-NP	O
therapeutic	therapeutic	JJ	I-NP	O
range	range	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
therapeutic	therapeutic	JJ	B-ADJP	O
on	on	IN	B-PP	O
heparin	heparin	NN	B-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
facility	facility	NN	I-NP	O
for	for	IN	B-PP	O
intensive	intensive	JJ	B-NP	O
conditioning	conditioning	NN	I-NP	O
and	and	CC	I-NP	O
rehabilitation	rehabilitation	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
she	she	PRP	B-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
receive	receive	VB	I-VP	O
her	her	PRP$	B-NP	O
heparin	heparin	NN	I-NP	O
until	until	IN	B-SBAR	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
therapeutic	therapeutic	JJ	B-ADJP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
dosing	dosing	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
handled	handle	VBN	I-VP	O
by	by	IN	B-PP	O
primary	primary	JJ	B-NP	O
care	care	NN	I-NP	O
doctor	doctor	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Corey	Corey	NNP	I-NP	O
Updegraff	Updegraff	NNP	I-NP	O
,	,	,	O	O
or	or	CC	O	O
a	a	DT	B-NP	O
physician	physician	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
rehabilitation	rehabilitation	NN	I-NP	O
center	center	NN	I-NP	O
.	.	.	O	O

Dr.	Dr.	NNP	B-NP	O
Turks	Turks	NNP	I-NP	O
's	's	POS	B-NP	O
number	number	NN	I-NP	O
is	be	VBZ	B-VP	O
250-940-9571	250-940-9571	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
goal	goal	NN	I-NP	B-protein
INR	INR	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
2	2	CD	B-NP	O
to	to	TO	B-PP	O
2.5	2.5	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
also	also	RB	I-VP	O
require	require	VB	I-VP	O
follow-up	follow-up	JJ	B-NP	O
chest	chest	NN	I-NP	O
x-rays	x-ray	NNS	I-NP	O
as	as	IN	B-PP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
bilateral	bilateral	JJ	B-NP	O
pleural	pleural	JJ	I-NP	O
effusions	effusion	NNS	I-NP	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
small	small	JJ	B-ADJP	O
and	and	CC	O	O
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
compromising	compromise	VBG	I-VP	O
her	her	PRP$	B-NP	O
respiration	respiration	NN	I-NP	O
at	at	IN	B-ADVP	O
all	all	DT	I-ADVP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Tylenol	Tylenol	NN	B-NP	O
#	#	#	B-NP	O
3	3	CD	I-NP	O
one	one	CD	I-NP	O
to	to	TO	I-NP	O
two	two	CD	I-NP	O
tablets	tablet	NNS	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.3-4h	q.3-4h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	JJ	B-NP	O
pain	pain	NN	I-NP	O
;	;	:	O	O
digoxin	digoxin	NN	B-NP	O
0.125	0.125	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
;	;	:	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
t.i.d.	t.i.d.	FW	I-ADVP	O
while	while	IN	B-SBAR	O
taking	take	VBG	B-VP	O
Tylenol	Tylenol	NN	B-NP	B-protein
#	#	#	B-NP	I-protein
3	3	CD	I-NP	I-protein
;	;	:	O	O
Lasix	Lasix	NNP	B-NP	O
80	80	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.d.	q.d.	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
initially	initially	RB	B-ADVP	O
but	but	CC	O	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
discontinued	discontinue	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
discretion	discretion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
or	or	CC	I-NP	O
cardiology	cardiology	NN	I-NP	O
physicians	physician	NNS	I-NP	O
,	,	,	O	O
pending	pende	VBG	B-PP	O
the	the	DT	B-NP	O
resolution	resolution	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
pleural	pleural	JJ	I-NP	O
effusions	effusion	NNS	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
respiratory	respiratory	JJ	I-NP	O
status	status	NN	I-NP	O
;	;	:	O	O
Synthroid	Synthroid	JJ	B-NP	O
150	150	CD	I-NP	O
micrograms	microgram	NNS	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
require	require	VB	I-VP	O
thyroid	thyroid	NN	B-NP	O
function	function	NN	I-NP	O
tests	test	NNS	I-NP	O
in	in	IN	B-PP	O
four	four	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

Multivitamin	Multivitamin	NN	B-NP	O
one	one	CD	I-NP	O
tablet	tablet	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
Coumadin	Coumadin	NN	B-NP	O
,	,	,	O	O
dose	dose	NN	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
determined	determine	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
INR	INR	NN	I-NP	B-protein
,	,	,	O	O
again	again	RB	B-ADVP	O
the	the	DT	B-NP	O
goal	goal	NN	I-NP	O
is	be	VBZ	B-VP	O
2	2	CD	B-NP	O
to	to	TO	B-PP	O
2.5	2.5	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
4	4	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
on	on	IN	B-PP	O
September	September	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
3	3	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
on	on	IN	B-PP	O
September	September	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
on	on	IN	B-PP	O
September	September	NNP	B-NP	O
is	be	VBZ	B-VP	O
1.3	1.3	CD	B-NP	O
.	.	.	O	O

Axid	Axid	NN	B-NP	O
150	150	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
;	;	:	O	O
K-Dur	K-Dur	NN	B-NP	O
10	10	CD	I-NP	O
mEq	mEq	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
will	will	MD	B-VP	O
also	also	RB	I-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
monitored	monitor	VBN	I-VP	O
while	while	IN	B-SBAR	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
Lasix	Lasix	NN	I-NP	B-DNA
;	;	:	O	I-DNA
intravenous	intravenous	JJ	B-NP	I-DNA
heparin	heparin	NN	I-NP	I-DNA
800	800	CD	B-NP	I-DNA
units	unit	NNS	I-NP	I-DNA
per	per	IN	B-PP	O
hour	hour	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
PTT	PTT	NN	I-NP	O
goal	goal	NN	I-NP	O
of	of	IN	B-PP	O
50-60	50-60	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
PTT	PTT	NN	I-NP	O
today	today	NN	B-NP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
dosing	dosing	NN	I-NP	O
is	be	VBZ	B-VP	O
54	54	CD	B-NP	O
.	.	.	O	O

FOLLOW-UP	FOLLOW-UP	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
follow-up	follow-up	VB	I-VP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Kale	Kale	NNP	I-NP	O
in	in	IN	B-PP	O
four	four	CD	B-NP	O
to	to	TO	I-NP	O
six	six	CD	I-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Nicklas	Nicklas	NNP	I-NP	O
in	in	IN	B-PP	O
two	two	CD	B-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Etheredge	Etheredge	NNP	I-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
to	to	TO	I-NP	O
two	two	CD	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
CALEB	CALEB	NNP	B-NP	O
POLASHEK	POLASHEK	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
FP11	FP11	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
JOHNATHAN	JOHNATHAN	NNP	B-NP	O
N.	N.	NNP	I-NP	O
REHLER	REHLER	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
QF7	QF7	NNP	I-NP	O
FS721/9446	FS721/9446	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
7950	7950	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

S6BWED7KF1	S6BWED7KF1	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
6/13/96	6/13/96	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
6/13/96	6/13/96	CD	B-NP	O

